Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju Hee Oh

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Clinical and Molecular Hepatology|April 29, 2022
Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trialJu Hee Oh, Dae Won Jun, Hye Young Kim, et al.
Biology Direct|August 25, 2023
Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver diseaseSeung Min Lee, Dae Won Jun, Eileen Laurel Yoon, et al.
Molecular Cancer Therapeutics|October 13, 2023
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in GlioblastomaWenjuan Zhang, Rachael A Vaubel, Ju-Hee Oh, et al.
Phytotherapy Research : PTR|July 20, 2007
Schizandra chinensis and Scutellaria baicalensis counter stress behaviors in miceSeungjoo Lee, Dong Hyun Kim, Ji Wook Jung, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2021
BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal modelHye Young Kim, Sang Bong Ahn, Jeong-Min Hong, et al.
Drug Development and Industrial Pharmacy|October 16, 2015
Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatinJu-Hee Oh, Ji Eun Lee, Yu Jeong Kim, et al.
Neuro-Oncology Advances|May 2, 2023
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence timeErica A Power, Julian S Rechberger, Liang Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2024
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain TumorsSneha Rathi, Ju-Hee Oh, Wenjuan Zhang, et al.
Life Science Alliance|May 21, 2025
Inhibition of xanthine oxidoreductase with febuxostat, but not allopurinol, prevents inflammasome assembly and IL-1β releaseLauar de Brito Monteiro, Anne-Sophie Archambault, Lucas F Starchuk, et al.
Journal of Clinical Neurology (Seoul, Korea)|October 13, 2016
Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced ParkinsonismJoong Seok Kim, Dong Woo Ryu, Ju Hee Oh, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Clinical and Molecular Hepatology|April 29, 2022
Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trialJu Hee Oh, Dae Won Jun, Hye Young Kim, et al.
Biology Direct|August 25, 2023
Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver diseaseSeung Min Lee, Dae Won Jun, Eileen Laurel Yoon, et al.
Molecular Cancer Therapeutics|October 13, 2023
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in GlioblastomaWenjuan Zhang, Rachael A Vaubel, Ju-Hee Oh, et al.
Phytotherapy Research : PTR|July 20, 2007
Schizandra chinensis and Scutellaria baicalensis counter stress behaviors in miceSeungjoo Lee, Dong Hyun Kim, Ji Wook Jung, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2021
BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal modelHye Young Kim, Sang Bong Ahn, Jeong-Min Hong, et al.
Drug Development and Industrial Pharmacy|October 16, 2015
Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatinJu-Hee Oh, Ji Eun Lee, Yu Jeong Kim, et al.
Neuro-Oncology Advances|May 2, 2023
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence timeErica A Power, Julian S Rechberger, Liang Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2024
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain TumorsSneha Rathi, Ju-Hee Oh, Wenjuan Zhang, et al.
Life Science Alliance|May 21, 2025
Inhibition of xanthine oxidoreductase with febuxostat, but not allopurinol, prevents inflammasome assembly and IL-1β releaseLauar de Brito Monteiro, Anne-Sophie Archambault, Lucas F Starchuk, et al.
Journal of Clinical Neurology (Seoul, Korea)|October 13, 2016
Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced ParkinsonismJoong Seok Kim, Dong Woo Ryu, Ju Hee Oh, et al.
Pageof 9